|
C12ORF48 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.338200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.958800E-01 |
| Normal-vs-Stage2 |
4.958100E-02 |
| Normal-vs-Stage3 |
6.484400E-01 |
| Normal-vs-Stage4 |
6.244200E-01 |
| Stage1-vs-Stage2 |
4.563800E-03 |
| Stage1-vs-Stage3 |
4.883200E-01 |
| Stage1-vs-Stage4 |
5.244400E-01 |
| Stage2-vs-Stage3 |
3.180400E-03 |
| Stage2-vs-Stage4 |
1.210960E-01 |
| Stage3-vs-Stage4 |
2.985800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.620800E-01 |
| Normal-vs-AfricanAmerican |
6.141000E-01 |
| Normal-vs-Asian |
5.769000E-01 |
| Caucasian-vs-AfricanAmerican |
3.594600E-01 |
| Caucasian-vs-Asian |
1.891810E-01 |
| AfricanAmerican-vs-Asian |
9.073000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.787600E-01 |
| Normal-vs-Female |
8.292600E-01 |
| Male-vs-Female |
9.384200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.891200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.809200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.009000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.777700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.944340E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.064400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.081800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.143200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.826700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.107800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.028200E-01 |
| Classical-VS-Follicular |
1.74839998035026E-09 |
| Classical-VS-Other |
9.764600E-03 |
| Classical-VS-Normal |
5.073400E-01 |
| Tall-VS-Follicular |
1.393930E-04 |
| Tall-VS-Other |
2.740800E-03 |
| Tall-VS-Normal |
1.611840E-01 |
| Follicular-VS-Other |
9.712400E-01 |
| Follicular-VS-Normal |
4.544500E-03 |
| Other-VS-Normal |
4.089900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.936400E-01 |
| Normal-vs-N1 |
7.925000E-01 |
| N0-vs-N1 |
2.279400E-01 |
|
|
